HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
mRNA and DNA-Based Vaccines

With their rapid development and scalable design, mRNA and DNA-based vaccines have reshaped the field of vaccinology. These nucleic acid platforms instruct cells to produce antigenic proteins, prompting strong immune responses without using live pathogens. Their flexibility allows quick updates for evolving threats, as seen with COVID-19 vaccines. Delivery systems like lipid nanoparticles and electroporation are continuously improving their stability and efficacy. Safety profiles, low production costs, and adaptability make these vaccines attractive for global deployment. As research expands into oncology and rare diseases, mRNA and DNA-Based Vaccines are establishing themselves as pivotal technologies in both preventive and therapeutic settings.

Committee Members
Speaker at International Vaccines Congress 2025 - Khursheed Anwer

Khursheed Anwer

IMUNON, United States
Speaker at International Vaccines Congress 2025 - Regina Au

Regina Au

BioMarketing Insight, United States
Speaker at International Vaccines Congress 2025 - Madhu Khanna

Madhu Khanna

University of Delhi, India
IVC 2025 Speakers
Speaker at International Vaccines Congress 2025 - Khursheed Anwer

Khursheed Anwer

IMUNON, United States
Speaker at International Vaccines Congress 2025 - Regina Au

Regina Au

BioMarketing Insight, United States
Speaker at International Vaccines Congress 2025 - Madhu Khanna

Madhu Khanna

University of Delhi, India
Speaker at International Vaccines Congress 2025 - Lara Isis Teodoro

Lara Isis Teodoro

Mayo Clinic, United States
Speaker at International Vaccines Congress 2025 - Ahmed Abdulazeez

Ahmed Abdulazeez

BHRUT Trust, United Kingdom
Speaker at International Vaccines Congress 2025 - Elena Chiappini

Elena Chiappini

University of Florence, Italy
Tags

Submit your abstract Today

Watsapp